Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uremic bone disease: current knowledge, controversial issues, and new horizons.

H H Malluche1, M C Monier-Faugere

  • 1University of Kentucky, Division of Nephrology, Bone and Mineral Metabolism, Lexington.

Mineral and Electrolyte Metabolism
|January 1, 1991
PubMed
Summary

Mineral and bone disorder is common in chronic kidney disease, impacting patient health. This review covers current knowledge, controversies, and future directions in managing renal osteodystrophy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

Clinical nephrology·2010
Same author

Tempora mutantur et nos mutamur in illis - Times are changing, and so are we.

Clinical nephrology·2009
Same author

The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.

Clinical nephrology·2009

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Mineral and bone metabolism abnormalities are early complications of renal failure.
  • Uremic bone disease significantly contributes to morbidity in end-stage renal failure patients.

Purpose of the Study:

  • To review current knowledge on mineral and bone metabolism in renal failure.
  • To discuss controversies, unresolved questions, and emerging issues in the field.

Main Methods:

  • Literature review of accepted knowledge.
  • Analysis of current controversies and new therapeutic approaches.

Main Results:

  • Abnormalities in mineral and bone metabolism are prevalent early in renal failure.

Related Experiment Videos

  • New therapies introduce novel challenges and debates.

    • Conclusions:

    • Understanding established knowledge is crucial for addressing ongoing controversies.
    • Future research should focus on unresolved questions and new therapeutic horizons.